Bank Of Marin Vertex Pharmaceuticals Inc Transaction History

Bank Of Marin

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$207.02 - $241.31 $179,693 - $209,457	-868 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $10,143 - $13,528	49 Added 5.98%	868 $205,000
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $16,617 - $19,701	65 Added 8.62%	819 $223,000
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $170,011 - $223,033	754 New	754 $219,000

1,625

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bank Of Marin, based on Form 13F filings with the SEC.

Stay updated on Bank Of Marin with notifications on news.